Boehringer Ingelheim has taken an option on a family of GPR52 agonist compounds with potential in schizophrenia from Sosei Heptares, in a €755m deal.

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

P OOR MENTAL health is a scourge. Prescriptions for anti-depressants and anti-anxiety medicines have soared in rich countries ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth ...

Tobacco was negatively associated with BD relapse while cannabis may have a more indirect effect on symptomology and the course of illness.

By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — AI programs can exhibit racial bias when ...

The medical watchdog is cracking down on doctors writing thousands of scripts a month for medicinal cannabis, with ...

Weed, gas, dope, spice, grass, green, hash, ganja, etcetera. There’s plenty of nicknames for it, and most names denote ...

Beneath the shadow of the bustling overpass on Chicago’s Near West Side, where Desplaines Street meets Hubbard, is an informal encampment residents call the “Chocolate Factory.” Jeremy Holomshek, ...

As Rachel Brosnahan becomes the latest actor to play Lois Lane in a ‘Superman’ movie, Adam White revisits the most ...